Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers.

Trial Profile

Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2010

At a glance

  • Drugs Nemonoxacin (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 01 Jan 2010 Results reported in Antimicrobial Agents and Chemotherapy.
    • 24 Oct 2007 Status change
    • 04 Oct 2007 Results have been presented.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top